IP Library › Assignment 025562/0340
Patent Assignment
Reel/Frame 025562/0340

Security Agreement

Recorded: 2010-12-23 Pages: 22
Assignor
NEUROTECH USA, INC.
Executed: 2010-12-23
Assignee
LFG AMERICA PTY LIMITED
LEVEL 23, 100 WILLIAM STREET, SYDNEY, AUSTRALIA
Covered Properties (24)
Implantable Biocompatible Immunoisolatory Vehicle for Delivery of Selected Therapeutic Products
Patent: 5,800,828 →
Application: 08/179,151 →
Methods for Treatment of Prevention of Neurodegenerative Conditions Using Immunoisolatory Implantable Vehicles with a Biocompatible Jacket and a Biocompatible Matrix Core
Patent: 5,871,767 →
Application: 08/449,062 →
Methods for Making Immunoisolatory Implantable Vehicles with a Bio- Compatible Jacket and a Biocompatible Matrix Core
Patent: 5,834,001 →
Application: 08/449,214 →
Methods for Coextruding Immunoisolatory Implantable Vehicles with a Biocompatible Jacket and a Biocompatible Matrix Core
Patent: 5,800,829 →
Application: 08/449,274 →
Implantable Biocompatible Immunoisolatory Vehicle for Delivery of Selected Therapeutic Products
Patent: 5,798,113 →
Application: 08/449,524 →
Methods for Treating Diabetes by Delivering Insulin from Biocompatible Cell-Containing Devices
Patent: 5,869,077 →
Application: 08/449,562 →
Delivery of Biologically Active Molecules Using Cells Contained in Bicompatible Immunoisolatory Capsules
Patent: 5,639,275 →
Application: 08/449,756 →
Methods for Making Immunoisolatory Implantable Vehicles with a Bio- Compatible Jacket and a Biocompatible Matrix Core
Patent: 5,874,099 →
Application: 08/449,837 →
Compositions and Methods for the Delivery of Biologically Active Molecules Using Cells Contained in Biocompatible Capsules
Patent: 5,656,481 →
Application: 08/449,946 →
Compositions and Methods for the Delivery of Biologically Active Molecules Using Genetically Altered Cells Contained in Biocompatible Immunoisolatory Capsules
Patent: 5,676,943 →
Application: 08/450,316 →
Compositions and Methods for the Delivery of Biologically Active Molecules Using Genetically Altered Cells Contained in Biocompatible Immunoisolatory Capsules
Patent: 5,908,623 →
Application: 08/450,862 →
Compositions and Methods for the Delivery of Biologically Active Molecules Using Cells Contained in Biocompatible Capsules
Patent: 5,653,975 →
Application: 08/451,044 →
Method for Treating Ophthalmic Diseases
Patent: 5,904,144 →
Application: 08/620,982 →
Implantable Biocompactable Immunoisolatory Vehicle for the Delivery of Selected Therapeutic Products
Patent: 6,083,523 →
Application: 09/148,671 →
Device and Method for Treating Ophthalmic Diseases
Patent: 6,299,895 →
Application: 09/155,066 →
Compositions for the Delivery of Biologically Active Molecules Using Genetically Altered Cells Contained in Biocompatible Immunoisolatory Capsules
Patent: 6,264,941 →
Application: 09/236,246 →
Cells or Tissue Attached to a Non- Degradable Filamentous Matrix Encapsulated by a Semi- Permeable Membrane
Patent: 6,303,136 →
Application: 09/289,999 →
ARPE-19 as a plateform cell line for encapsulated cell-based delivery
Patent: 6,361,771 →
Application: 09/543,119 →
Implantable biocompatible immunoisolatory vehicle for the delivery of selected therapeutic products
Patent: 6,322,804 →
Application: 09/563,248 →
Device Containing Cell-Supporting Yarn Matrix Encapsulated in a Semi-Permeable Membrane
Patent: 6,627,422 →
Application: 09/673,339 →
Arpe-19 as a Platform Cell Line for Encapsulated Cell-Based Delivery
Patent: 7,115,257 →
Application: 09/958,040 →
Device and Method for Treating Ophthalmic Diseases
Patent: 6,436,427 →
Application: 09/973,325 →
Publication: US 2002/0061327
Device and Method for Treating Ophthalmic Diseases
Patent: 6,649,184 →
Application: 10/224,521 →
Publication: US 2003/0031700
Implantable Biocompatible Immunoisolatory Vehicle for Delivery of Selected Therapeutic Products
Patent: 6,960,351 →
Application: 10/624,081 →
Publication: US 2004/0185083
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest May 9, 1994
From: DIONNE, KEITH E.; EMERICH, DWAINE F.; HOFFMAN, DIANE; SANBERG, PAUL R.
To: BROWN UNIVERSITY RESEARCH FOUNDATION
Reel/Frame 006984/0309 →
Assignment of Assignor's Interest Jul 28, 1995
From: BAETGE, EDWARD E.; HAMMANG, JOSEPH P.; GENTILE, FRANK T.; LINDNER, MARK D.
To: CYTOTHERAPEUTICS, INC.
Reel/Frame 007559/0299 →
Assignment of Assignor's Interest Jul 28, 1995
From: BAETGE, EDWARD E.; HAMMANG, JOSEPH P.; GENTILE, FRANK T.; LINDNER, MARK D.
To: CYTOTHERAPEUTICS, INC.
Reel/Frame 007581/0661 →
Assignment of Assignor's Interest Jul 28, 1995
From: BAETGE, EDWARD E.; HAMMANS, JOSEPH P.; GENTILE, FRANK T.; LINDNER, MARK D.
To: CYTOTHERAPEUTICS, INC.
Reel/Frame 007556/0697 →
Assignment of Assignor's Interest Jul 28, 1995
From: BAETGE, EDWARD E.; HAMMANG, JOSEPH P.; GENTILE, FRANK T.; LINDNER, MARK D.
To: CYTOTHERAPEUTICS, INC.
Reel/Frame 007556/0745 →
Assignment of Assignor's Interest Jul 28, 1995
From: BAETGE, EDWARD E.; HAMMANG, JOSEPH P.; GENTILE, FRANK T.; LINDNER, MARK D.
To: CYTOTHERAPEUTICS, INC.
Reel/Frame 007556/0912 →
Assignment of Assignor's Interest Apr 27, 1999
From: HAMMANG, JOSEPH P.; BAETGE, E. EDWARD; TSIARAS, WILLIAM G.
To: CYTOTHERAPEUTICS, INC.
Reel/Frame 009930/0865 →
Assignment of Assignor's Interest Oct 28, 1999
From: LI, REBECCA; REIN, DAVID
To: CYTOTHERAPEUTICS, INC.
Reel/Frame 010348/0541 →
Assignment of Assignor's Interest Feb 7, 2000
From: CYTOTHERAPEUTICS, INC.
To: NEUROTECH S.A.
Reel/Frame 010567/0917 →
Assignment of Assignor's Interest Oct 24, 2000
From: TAO, WENG; REIN, DAVID H.; DEAN, BRENDA J.; STABILA, PAUL F.
To: NEUROTECH S.A.
Reel/Frame 011211/0956 →
Assignment of Assignor's Interest Feb 6, 2001
From: LI, REBECCA; REIN, DAVID
To: NEUROTECH S.A.
Reel/Frame 011505/0867 →
Assignment of Assignor's Interest Jan 25, 2002
From: TAO, WENG; REIN, DAVID H.; DEAN, BRENDA J.; STABILIA, PAUL F.
To: NEUROTECH S.A.
Reel/Frame 012556/0574 →
Assignment of Assignor's Interest Apr 12, 2002
From: CYTOTHERAPEUTICS, INC.
To: NEUROTECH S.A.
Reel/Frame 012829/0211 →
Assignment of Assignor's Interest Sep 12, 2003
From: HAMMANG, JOSEPH P.; BAETGE, E. EDWARD; TSIARAS, WILLIAM G.
To: CYTOTHERAPEUTICS, INC.
Reel/Frame 014492/0054 →
Assignment of Assignor's Interest Sep 16, 2003
From: CYTOTHERAPEUTICS, INC.
To: NEUROTECH S.A.
Reel/Frame 014498/0712 →
Assignment of Assignor's Interest Dec 12, 2005
From: CYTOTHERAPEUTICS, INC.
To: NEUROTECH S.A.
Reel/Frame 017073/0187 →
Assignment of Assignor's Interest Apr 5, 2006
From: CYTOTHERAPEUTICS, INC.
To: NEUROTECH S.A.
Reel/Frame 017794/0001 →
Assignment of Assignor's Interest Mar 26, 2007
From: SPEAR, PETER D.
To: WISCONSIN ALUMNI RESEARCH FOUNDATION
Reel/Frame 019062/0492 →
Assignment of Assignor's Interest Mar 26, 2007
From: SPEAR, PETER D.
To: WISCONSIN ALUMNI RESEARCH FOUNDATION
Reel/Frame 019062/0448 →
Assignment of Assignor's Interest Mar 26, 2007
From: SPEAR, PETER D.
To: WISCONSIN ALUMNI RESEARCH FOUNDATION
Reel/Frame 019062/0410 →
Assignment of Assignor's Interest Feb 11, 2008
From: NEUROTECH, S.A.
To: NEUROTECH USA, INC.
Reel/Frame 020487/0321 →
Confirmatory License Dec 18, 2008
From: UNIVERSITY OF WISCONSIN-MADISON
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 022003/0951 →
Executive Order 9424, Confirmatory License Dec 18, 2008
From: UNIVERSITY OF WISCONSIN-MADISON
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 022002/0635 →
Executive Order 9424, Confirmatory License Dec 18, 2008
From: UNIVERSITY OF WISCONSIN-MADISON
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 022003/0955 →
Executive Order 9424, Confirmatory License Dec 18, 2008
From: UNIVERSITY OF WISCONSIN-MADISON
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 022003/0963 →